AC
AXQ Capital Portfolio holdings
AUM
$310M
This Quarter Return
+10%
1 Year Return
+4.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$144M
AUM Growth
–
Cap. Flow
+$144M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
10.04%
Holding
314
New
314
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.6M |
| 2 |
Apple
AAPL
|
$1.57M |
| 3 |
Nike
NKE
|
$1.53M |
| 4 |
Visa
V
|
$1.46M |
| 5 |
Synopsys
SNPS
|
$1.41M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Discretionary | 17.15% |
| 2 | Technology | 16.64% |
| 3 | Healthcare | 15.45% |
| 4 | Financials | 14.34% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
BlackBerry
BB
$2.28B
| $93.7K | 0.07% |
+28,739
| New | +$93.7K |
|
302
Nkarta
NKTX
$151M
| $92.5K | 0.06% |
+15,444
| New | +$92.5K |
|
303
Berry Corp
BRY
$259M
| $88.7K | 0.06% |
+11,083
| New | +$88.7K |
|
304
ImmunityBio
IBRX
$2.21B
| $83.2K | 0.06% |
+16,407
| New | +$83.2K |
|
305
Haleon
HLN
$43.9B
| $81.6K | 0.06% |
+10,200
| New | +$81.6K |
|
|
BLUE
306
DELISTED
bluebird bio
BLUE
| $78.7K | 0.05% |
+11,370
| New | +$78.7K |
|
307
iQIYI
IQ
$2.55B
| $78.4K | 0.05% |
+14,800
| New | +$78.4K |
|
308
MannKind Corp
MNKD
$1.41B
| $66.9K | 0.05% |
+12,700
| New | +$66.9K |
|
309
Sabre
SABR
$706M
| $66.9K | 0.05% |
+10,825
| New | +$66.9K |
|
|
ETWO
310
DELISTED
E2open Parent Holdings
ETWO
| $60.5K | 0.04% |
+10,302
| New | +$60.5K |
|
311
Relmada Therapeutics
RLMD
$37.2M
| $43.6K | 0.03% |
+12,483
| New | +$43.6K |
|
|
RAD
312
DELISTED
Rite Aid Corporation
RAD
| $42.7K | 0.03% |
+12,789
| New | +$42.7K |
|
313
Gossamer Bio
GOSS
$562M
| $35.5K | 0.02% |
+16,372
| New | +$35.5K |
|
|
TSP
314
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $31.6K | 0.02% |
+19,270
| New | +$31.6K |
|